Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis B

European Journal of Internal Medicine

Volumn 13, Issue 2, 2002, Pages 129-131

  Husa, Petr ^a   Klusáková, Jarmila ^a   Jančíková, Jana ^a   Husová, Libuše ^a   Horálek, František ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Adverse events; Chronic hepatitis B; Interferon alpha; Mediastinal lymphadenopathy; Spontaneous remission of sarcoidosis

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DNA DETERMINATION; DOSE CALCULATION; DRUG POTENCY; DRUG TOLERANCE; FOLLOW UP; HEPATITIS B; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNITY; INFLUENZA; LYMPHADENECTOMY; LYMPHADENOPATHY; MALE; MEDIASTINUM; SARCOIDOSIS; TH1 CELL; THORACOSCOPY; THORAX RADIOGRAPHY; TIME; TUMOR;

EID: 0036124532     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(02)00005-5     Document Type: Article

References (12)

1. A survey of adverse events in 11 241 patients with viral hepatitis treated with alfa interferon
2. Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C
3. Interstitial pneumonia caused by interferon-alpha in chronic myelogenous leukemia
4. Sarcoidosis after interferon therapy for chronic active hepatitis C
5. Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C
6. Sarcoidosis associated with interferon-alfa therapy for chronic hepatitis C
7. Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma
8. Improvement of sarcoidosis under therapy with interferon-alfa 2b for chronic hepatitis B virus infection
9. Pulmonary sarcoidosis. A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity
10. Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors in T-lymphocytes in the blood of individuals with active pulmonary sarcoidosis
11. Limited heterogeneity of biased T-cell receptor V beta gene usage in lung but not in blood T cells in active pulmonary sarcoidosis
12. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis